Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival

Blood

Volumn 121, Issue 10, 2013, Pages 1795-1804

  Venkataraman, Girish ^a   Song, Joo Y ^a   Tzankov, Alexandar ^b   Dirnhofer, Stephan ^b   Heinze, Georg ^c   Kohl, Maria ^c   Traverse Glehen, Alexandra ^d   Eberle, Franziska C ^a   Hanson, Jeffrey C ^a   Raffeld, Mark A ^a   Pittaluga, Stefania ^a   Jaffe, Elaine S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; T LYMPHOCYTE ANTIGEN; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHILD; CLONAL VARIATION; EVENT FREE SURVIVAL; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NODULAR SCLEROSIS HODGKIN LYMPHOMA; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD;

EID: 84876534485     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-06-439455     Document Type: Article

References (50)

1. Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med. 1998;339(21):1506-1514.
2. Steidl C, Lee T, Shah SP, et al. Tumorassociated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med. 2010; 362(10):875-885.
3. Tzankov A, Matter MS, Dirnhofer S. Refined prognostic role of CD68-positive tumor macrophages in the context of the cellular micromilieu of classical Hodgkin lymphoma. Pathobiology. 2010;77(6):301-308.
4. Farinha P, Rodrigues S, Fernandes T, et al. Lymphoma Associated Macrophages Predict Survival in Uniformly Treated Patients with Classical Hodgkin Lymphoma. San Antonio, TX: United States and Canadian Academy of Pathology; 2011.
5. Chetaille B, Bertucci F, Finetti P, et al. Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome. Blood. 2009;113(12):2765-3775.
6. Alvaro T, Lejeune M, Salvad'o MT, et al. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res. 2005;11(4): 1467-1473. (Pubitemid 40315228)
7. Alvaro-Naranjo T, Lejeune M, Salvad'o-Usach MT, et al. Tumor-infiltrating cells as a prognostic factor in Hodgkin's lymphoma: a quantitative tissue microarray study in a large retrospective cohort of 267 patients. Leuk Lymphoma. 2005;46(11): 1581-1591. (Pubitemid 41700991)
8. Portlock CS, Donnelly GB, Qin J, et al. Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin's disease. Br J Haematol. 2004;125(6):701-708. (Pubitemid 38813596)
9. Rassidakis GZ, Medeiros LJ, Vassilakopoulos TP, et al. BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens. Blood. 2002; 100(12):3935-3941. (Pubitemid 35396858)
10. Doussis-Anagnostopoulou IA, Vassilakopoulos TP, Thymara I, et al. Topoisomerase IIalpha expression as an independent prognostic factor in Hodgkin's lymphoma. Clin Cancer Res. 2008; 14(6):1759-1766. (Pubitemid 351469461)
11. Kǔppers R, Rajewsky K, Zhao M, et al. Hodgkin's disease: Hodgkin and Reed Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci USA. 1994; 91(23):10962-10966.
12. Hummel M, Ziemann K, Lammert H, et al. Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells. N Engl J Med. 1995;333(14):901-906.
13. Delabie J, Tierens A, Gavriil T, et al. Phenotype, genotype and clonality of Reed-Sternberg cells in nodular sclerosis Hodgkin's disease: results of a single-cell study. Br J Haematol. 1996;94(1): 198-205. (Pubitemid 26232566)
14. Al Saati T, Galoin S, Gravel S, et al. IgH and TcR-gamma gene rearrangements identified in Hodgkin's disease by PCR demonstrate lack of correlation between genotype, phenotype, and Epstein-Barr virus status. J Pathol. 1997;181(4): 387-393. (Pubitemid 27223523)
15. Kǔppers R, Hansmann ML, Rajewsky K. Clonality and germinal centre B-cell derivation of Hodgkin/Reed-Sternberg cells in Hodgkin's disease. Ann Oncol. 1998;9(Suppl 5):S17-S20. (Pubitemid 29049112)
16. Kanzler H, Kǔppers R, Hansmann ML, et al. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med. 1996;184(4): 1495-1505. (Pubitemid 26354704)
17. Hummel M, Marafioti T, Stein H. Clonality of Reed-Sternberg cells in Hodgkin's disease. N Engl J Med. 1999;340(5):394-395. (Pubitemid 29090814)
18. Marafioti T, Hummel M, Foss HD, et al. Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood. 2000;95(4):1443-1450. (Pubitemid 30099859)
19. Falini B, Stein H, Pileri S, et al. Expression of lymphoid-associated antigens on Hodgkin's and Reed-Sternberg cells of Hodgkin's disease. An immunocytochemical study on lymph node cytospins using monoclonal antibodies. Histopathology. 1987;11(12):1229-1242. (Pubitemid 18097841)
20. Kadin ME, Muramoto L, Said J. Expression of T-cell antigens on Reed-Sternberg cells in a subset of patients with nodular sclerosing and mixed cellularity Hodgkin's disease. Am J Pathol. 1988;130(2):345-353. (Pubitemid 18076369)
21. Oudejans JJ, Kummer JA, Jiwa M, et al. Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease. Am J Pathol. 1996;148(1): 233-240. (Pubitemid 26022452)
22. Krenacs L, Wellmann A, Sorbara L, et al. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T-and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. Blood. 1997;89(3):980-989. (Pubitemid 27121292)
23. Mǔschen M, Rajewsky K, Brǎuninger A, et al. Rare occurrence of classical Hodgkin's disease as a T cell lymphoma. J Exp Med. 2000;191(2): 387-394. (Pubitemid 30060928)
24. Seitz V, Hummel M, Marafioti T, et al. Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease. Blood. 2000;95(10):3020-3024. (Pubitemid 30321149)
25. Tzankov A, Bourgau C, Kaiser A, et al. Rare expression of T-cell markers in classical Hodgkin's lymphoma. Mod Pathol. 2005;18(12): 1542-1549. (Pubitemid 41670652)
26. Asano N, Oshiro A, Matsuo K, et al. Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study. J Clin Oncol. 2006; 24(28):4626-4633. (Pubitemid 46630961)
27. Swerdlow SH, Campo E, Harris NL. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed. Lyons, France: IARC press; 2008.
28. Haybittle JL, Hayhoe FG, Easterling MJ, et al. Review of British National Lymphoma Investigation studies of Hodgkin's disease and development of prognostic index. Lancet. 1985; 1(8435):967-972. (Pubitemid 15123968)
29. Stein H, Delsol G, Pileri S, et al. Classical Hodgkin lymphoma. In: Swerdlow SH, Campo E, Harris NL, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyons, France: IARC press; 2001.
30. von Wasielewski R, Seth S, Franklin J, et al. Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors. Blood. 2000;95(4):1207-1213. (Pubitemid 30099828)
31. von Wasielewski S, Franklin J, Fischer R, et al. Nodular sclerosing Hodgkin disease: new grading predicts prognosis in intermediate and advanced stages. Blood. 2003;101(10):4063-4069. (Pubitemid 36857887)
32. Dojcinov SD, Venkataraman G, Raffeld M, et al. EBV positive mucocutaneous ulcer -A study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol. 2010; 34(3):405-417.
33. Ramasamy I, Brisco M, Morley A. Improved PCR method for detecting monoclonal immunoglobulin heavy chain rearrangement in B cell neoplasms. J Clin Pathol. 1992;45(9):770-775.
34. van Dongen JJ, Langerak AW, Brǔggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17(12):2257-2317. (Pubitemid 38072572)
35. Lawnicki LC, Rubocki RJ, Chan WC, et al. The distribution of gene segments in T-cell receptor gamma gene rearrangements demonstrates the need for multiple primer sets. J Mol Diagn. 2003; 5(2):82-87. (Pubitemid 36559488)
36. Meier VS, Rufle A, Gudat F. Simultaneous evaluation of T-and B-cell clonality, t(11;14) and t (14;18), in a single reaction by a four-color multiplex polymerase chain reaction assay and automated high-resolution fragment analysis: a method for the rapid molecular diagnosis of lymphoproliferative disorders applicable to fresh frozen and formalin-fixed, paraffin-embedded tissues, blood, and bone marrow aspirates. Am J Pathol. 2001;159(6):2031-2043. (Pubitemid 33107308)
37. Cox DR. Regression models and life-tables (with discussion). J R Stat Soc Ser B. 1972;34: 184-220.
38. White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med. 2011;30(4): 377-399.
39. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: John Wiley & Sons; 1987.
40. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57: 375-386.
41. Eberle FC, Hanson JC, Killian JK, et al. Immunoguided laser assisted microdissection techniques for DNA methylation analysis of archival tissue specimens. J Mol Diagn. 2010; 12(4):394-401.
42. Lamprecht B, Walter K, Kreher S, et al. Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. Nat Med. 2010;16(5):571-579, 1 p following 579.
43. Griesser H, Feller AC, Mak TW, et al. Clonal rearrangements of T-cell receptor and immunoglobulin genes and immunophenotypic antigen expression in different subclasses of Hodgkin's disease. Int J Cancer. 1987;40(2): 157-160. (Pubitemid 17130828)
44. Foss HD, Reusch R, Demel G, et al. Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin. Blood. 1999;94(9):3108-3113. (Pubitemid 29512717)
45. Garc'ia-Cos'io M, Sant'on A, Mart'in P, et al. Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma. Mod Pathol. 2004;17(12): 1531-1538.
46. Cobaleda C, Jochum W, Busslinger M. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature. 2007;449(7161):473-477. (Pubitemid 47509547)
47. Tzankov AS, Went PT, Mǔnst S, et al. Rare expression of BSAP (PAX-5) in mature T-cell lymphomas. Mod Pathol. 2007;20(6):632-637. (Pubitemid 46795145)
48. Feldman AL, Law ME, Inwards DJ, et al. PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus. Mod Pathol. 2010;23(4):593-602.
49. Brǎuninger A, Hansmann ML, Strickler JG, et al. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N Engl J Med. 1999;340(16):1239-1247. (Pubitemid 29181644)
50. Marafioti T, Hummel M, Anagnostopoulos I, et al. Classical Hodgkin's disease and follicular lymphoma originating from the same germinal center B cell. J Clin Oncol. 1999;17(12): 3804-3809.